Rtw Investments, LP Oyster Point Pharma, Inc. Transaction History

Rtw Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$7.95 - $11.68 $2.07 Million - $3.04 Million	260,665 Added 12.75%	2,304,977 $25.7 Million
Q3 2022 Nov 14, 2022	SELL	$4.41 - $8.38 $62,586 - $118,928	-14,192 Reduced 0.69%	2,044,312 $11.5 Million
Q4 2021 Feb 14, 2022	BUY	$10.17 - $18.96 $2.01 Million - $3.74 Million	197,295 Added 10.6%	2,058,504 $37.6 Million
Q1 2021 May 14, 2021	SELL	$17.92 - $25.86 $1.15 Million - $1.66 Million	-64,385 Reduced 3.34%	1,861,209 $34 Million
Q4 2020 Feb 16, 2021	BUY	$18.13 - $25.18 $30,839 - $42,831	1,701 Added 0.09%	1,925,594 $36.2 Million
Q3 2020 Nov 16, 2020	BUY	$17.83 - $29.12 $259,123 - $423,200	14,533 Added 0.76%	1,923,893 $40.6 Million
Q2 2020 Aug 14, 2020	BUY	$27.86 - $35.93 $26.2 Million - $33.8 Million	939,882 Added 96.95%	1,909,360 $55.1 Million
Q1 2020 May 15, 2020	BUY	$23.65 - $40.96 $22.9 Million - $39.7 Million	969,478 New	969,478 $33.9 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.